Article
A quality control program for mutation detection in KIT and PDGFRA in gastrointestinal stromal tumours.
Journal of gastroenterology - 1 May 2011
Hostein Isabelle, Debiec-Rychter Maria, Olschwang Sylvianne, Bringuier Pierre-Paul, Toffolati Louisa, Gonzalez David, Forget Sébastien, Escande Fabienne, Morzuch Lucyna, Tamborini Elena, Faur Nicolas, Pilotti Silvana, Dei Tos Paolo, Emile Jean-François, Coindre Jean-Michel
Abstract excerpt
BACKGROUND: Although most gastrointestinal stromal tumours (GIST) carry oncogenic mutations in KIT exons 9, 11, 13 and 17, or in platelet-derived growth factor receptor alpha (PDGFRA) exons 12, 14 and 18, around 10% of GIST are free of these mutations. Genotyping and accurate detection of KIT/PDGFRA mutations in GIST are becoming increasingly useful for clinicians in the management of the disease. METHOD: To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
